Novel Biomarkers for Early Detection of Hepatocellular Carcinoma.

Autor: Attia AM; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Rezaee-Zavareh MS; Middle East Liver Diseases (MELD) Center, Tehran 1417935840, Iran., Hwang SY; Department of Internal Medicine, University of Maryland Medical Center, Midtown Campus, Baltimore, MD 21201, USA., Kim N; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Adetyan H; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Yalda T; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Chen PJ; Department of Hematology and Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Koltsova EK; Cedars-Sinai Cancer, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Yang JD; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Oct 13; Vol. 14 (20). Date of Electronic Publication: 2024 Oct 13.

Reply to correspondence on "Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets".

Autor: Rezaee-Zavareh MS; Middle East Liver Diseases Center, Tehran, Iran., Kim N; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Yang JD; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Publikováno v: Clinical and molecular hepatology [Clin Mol Hepatol] 2024 Oct; Vol. 30 (4), pp. 1037-1038. Date of Electronic Publication: 2024 May 02.

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.

Autor: Rezaee-Zavareh MS; Middle East Liver Diseases Center, Tehran 1417935840, Iran., Yeo YH; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles 90048, CA, USA., Wang T; Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, China; Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation), Guangzhou, China., Guo Z; Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, China; Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation), Guangzhou, China., Tabrizian P; Recanati/Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY, USA., Ward SC; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Barakat F; Southern California Liver Centers, 131 Orange Avenue, Suite 101, Coronado, CA, 92118, USA., Hassanein TI; Southern California Liver Centers, 131 Orange Avenue, Suite 101, Coronado, CA, 92118, USA., Shravan D; Division of Gastroenterology & Hepatology, Department of Medicine, University of California, San Diego, La Jolla CA, USA., Veeral A; Division of Gastroenterology & Hepatology, Department of Medicine, University of California, San Diego, La Jolla CA, USA., Bhoori S; HPB Surgery, Hepatology and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Mazzaferro V; HPB Surgery, Hepatology and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Department of Oncology, and Hemato-Oncology University of Milan, Milan, Italy., Chascsa DMH; Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA; Transplant Center, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA., Liu MC; Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA., Aby ES; Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN, USA., Lake JR; Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN, USA., Sogbe M; Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain., Sangro B; Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain., Abdelrahim M; Section of GI Oncology, Department of Medical Oncology, Houston Methodist Neal Cancer Center, Houston, TX 77030, USA; Cockrell Center of Advanced Therapeutics Phase I Program, Houston Methodist Research Institute, Houston, TX 77030, USA; Department of Internal Medicine, Weill Cornell Medical College, New York, NY 10021, USA., Esmail A; Section of GI Oncology, Department of Medical Oncology, Houston Methodist Neal Cancer Center, Houston, TX 77030, USA; Cancer Clinical Trials, Houston Methodist Research Institute, Houston, TX 77030, USA., Schmiderer A; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University of Innsbruck, Innsbruck, Austria., Chouik Y; Cancer Research Center of Lyon (CRCL), INSERM U1052, Centre National de la Recherche Scientifique UMR5286, Lyon, France; Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France., Rudolph M; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA., Sohal D; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA., Giudicelli H; AP-HP Sorbonne Université, Hôpital Universitaire Pitié-Salpêtrière, Service d'Hépato-gastroentérologie, Paris, France., Allaire M; AP-HP Sorbonne Université, Hôpital Universitaire Pitié-Salpêtrière, Service d'Hépato-gastroentérologie, Paris, France; INSERM UMR 1138, Centre de recherche des Cordeliers, 75006 Paris, France., Akce M; Division of Hematology and Oncology, Department of Medicine, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA., Guadagno J; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Tow CY; Division of Hepatology, Montefiore Medical Center, Bronx, New York; Albert Einstein College of Medicine, Bronx, NY, USA., Massoumi H; Division of Hepatology, Northwell 261 East 78th Street, Floor 4, New York, NY 10075, USA., De Simone P; Hepatobiliary Surgery and liver Transplantation, University of Pisa Medical School Hospital, Via Paradisa 2, Pisa, 56124, Italy., Kang E; Department of Pediatrics, Division of Pediatric Hematology/Oncology/SCT, Columbia University Irving Medical Center, New York, New York, USA., Gartrell RD; Department of Pediatrics, Division of Pediatric Hematology/Oncology/SCT, Columbia University Irving Medical Center, New York, New York, USA; Department of Oncology, Division of Pediatric Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Martinez M; Department of Pediatrics. Vagelos College of Physician and Surgeons. Columbia University, USA., Paz-Fumagalli R; Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA., Toskich BB; Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, FL 32224, USA., Tran NH; Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA., Solino GA; Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória - Department of Internal Medicine - Vitória/ES - Brazil., Poltronieri Pacheco DM; Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória - Department of Gastroenterology and Hepatology - Vitória/ES - Brazil., Kalman RS; Division of Hepatology, Department of Medicine, Einstein Healthcare Network, Philadelphia, Pennsylvania, USA., Agopian VG; The Dumont-University of California, Los Angeles, Transplant Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA., Mehta N; Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco, USA., Parikh ND; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA., Singal AG; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States., Yang JD; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles 90048, CA, USA; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles 90048, CA, USA; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles 90048, CA, USA. Electronic address: judong.yang@cshs.org.

Publikováno v: Journal of hepatology [J Hepatol] 2024 Jul 10. Date of Electronic Publication: 2024 Jul 10.

Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization.

Autor: Rezaee-Zavareh MS; Middle East Liver Diseases Center, Tehran, Iran., Kim N; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Yang JD; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Publikováno v: Clinical and molecular hepatology [Clin Mol Hepatol] 2024 Apr; Vol. 30 (2), pp. 150-153. Date of Electronic Publication: 2024 Feb 22.

Primary liver cancer spectrum: current knowledge and the next steps.

Autor: Rezaee-Zavareh MS; Middle East Liver Diseases Center, Tehran, Iran., Koltsova EK; Cedars-Sinai Cancer, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Hoshida Y; Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Yang JD; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Publikováno v: Hepatobiliary surgery and nutrition [Hepatobiliary Surg Nutr] 2024 Feb 01; Vol. 13 (1), pp. 157-160. Date of Electronic Publication: 2024 Jan 15.